Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9265763
APP PUB NO 20140249133A1
SERIAL NO

14350160

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of formula (I) which are inhibitors of Bub1 kinase, processes for their production and their use as pharmaceuticals.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BAYER INTELLECTUAL PROPERTY GMBH;BAYER PHARMA AKTIENGESELLSCHAFT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Briem, Hans Berlin, DE 88 611
Eis, Knut Berlin, DE 69 515
Fanghänel, Jörg Berlin, DE 6 174
Fernandez-Montalvan, Amaury Ernesto Berlin, DE 36 116
Gnoth, Mark Jean Mettmann, DE 47 531
Hitchcock, Marion Berlin, DE 34 100
Holton, Simon Berlin, DE 36 83
Lienau, Philip Berlin, DE 130 529
Mengel, Anne Berlin, DE 54 255
Pütter, Vera Berlin, DE 10 22
Prechtl, Stefan Berlin, DE 17 55
Preusse, Cornelia Berlin, DE 5 9
Schulze, Volker Bergfelde, DE 47 189
Siemeister, Gerhard Berlin, DE 144 993
Wengner, Antje Margret Berlin, DE 56 135

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 23, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00